Dietary Interventions in Liver Disease

Ronald Ross Watson, PhD, is Professor of Health Promotion Sciences at the University of Arizona, Mel and Enid Zuckerman College of Public Health. Dr. Watson began his research in public health at the Harvard School of Public Health as a Fellow in 1971 doing field work on vaccines in Saudi Arabia. He has done clinical studies in Colombia, Iran, Egypt, Saudi Arabia and the United States which provides a broad international view of public health. He has served in the military reserve hospital for 17 years with extensive training in medical responses to disasters as the chief biochemistry officer of a general hospital, retiring as a Lt. Colonel. He is a distinguished member of several national and international nutrition, immunology, and cancer societies. Dr. Watson’s career has involved studying many lifestyle aspects for their uses in health promotion. He has edited over 100 biomedical reference books and 450 papers and chapters. His teaching and research focuses on alcohol, tobacco, and drugs of abuse in heart function and disease in mouse models. Victor R. Preedy BSc, PhD, DSc, FRSB, FRSPH, FRSC, FRCPath graduated with an Honours Degree in Biology and Physiology with Pharmacology. After gaining his University of London PhD, he received his Membership of the Royal College of Pathologists. He was later awarded his second doctorate (DSc), for his contribution to protein metabolism in health and disease. He is Professor of Clinical Biochemistry (Hon) at King’s College Hospital and Emeritus Professor of Nutritional Biochemistry at King’s College London. He has Honorary Professorships at the University of Hull, and the University of Suffolk. Professor Preedy was the Founding Director and then long-term Director of the Genomics Centre at King’s College London from 2006 to 2020. Professor Preedy has been awarded fellowships of the Royal Society of Biology, the Royal College of Pathologists, the Royal Society for the Promotion of Health, the Royal Institute of Public Health, the Royal Society for Public Health, the Royal Society of Chemistry and the Royal Society of Medicine. He carried out research when attached to the National Heart Hospital (part of Imperial College London), The School of Pharmacy (now part of University College London) and the MRC Centre at Northwick Park Hospital. He has collaborated with international research groups in Finland, Japan, Australia, USA, and Germany. To his credit, Professor Preedy has published over 750 articles, which includes peer-reviewed manuscripts based on original research, abstracts and symposium presentations, reviews and edited books.

• 1. Genome-Based Nutrition in Chronic Liver Disease2. Current management and therapeutic strategies for alcoholic liver disease3. Features of hepatic encephalopathy4. The liver before and after bariatric surgery  5. Oxidative stress and dysfunction of the intracellular proteolytic machinery: a pathological hallmark of nonalcoholic fatty liver diseaseB. Fruits Improves liver health6. Polyphenols in the management of chronic liver diseases including hepatocellular carcinoma7. Phytochemicals in the prevention of ethanol-induced hepatotoxicity: a revisit8. Protective actions of polyphenols in the development of non-alcoholic fatty liver disease 9. Phytotherapy for the LiverC. Herbs and plants for treating liver disease10. Curcuma longa, the polyphenolic curcumin compound and pharmacological effect on liver11. Nymphaea alba and liver protection12. The Flavone Baicalein and its Use in Gastrointestinal Disease13. Pyrroloquinoline quinone: Its profile and effects on the liver: implications for health and disease prevention14. Herbal Weight Loss Supplements: from Dubious Efficacy to Direct Toxicity15. Tea (Camellia sinensis L. Kuntze) as hepatoprotective agent: a revisit16. Hepatoprotective Effects of the Indian Gooseberry (Emblica officinalis Gaertn): a revisitD. Dietary macronutrients and micronutrients for healthy liver function17. Dietary Interventions in Liver Disease 18. The effects of dietary advanced glycation end products (AGEs) on liver disorders19. Molecular mechanisms of the protective role of wheat germ oil against oxidative stress-induced liver disease20. Critical Role of Hepatic Fatty-acyl Phospholipid Remodeling in Obese and Non-Obese Fatty Liver Mouse Models21. Vitamin D3 and liver protection22. The Role of Carbohydrate Response Element Binding Protein in the Pathogenesis of Liver Disease23. Dietary Interventions in Liver Disease: Foods, Nutrients, and Dietary Supplements24. Fish Oil Supplements during Perinatal Life: Impact on the Liver of Offspring25. Purple Rice Bran Improve Hepatic Insulin Signaling via Activation of Akt and Stabilization of IGF in Diabetic RatsE. Toxic dietary materials including alcohol induced liver dysfunction: treatment26. Heavy Metals and low oxygen microenvironment- its impact on liver metabolism and dietary supplementation27. Cadmium and Fullerenes in Liver Diseases28. Beneficial effects of natural compounds on heavy metal-induced hepatotoxicity29. Nutritional and Dietary Intervention for Nonalcoholic Fatty Liver Disease30. Dietary management of non-alcoholic fatty liver disease (NAFLD) by n-3 polyunsaturated fatty acid (PUFA) supplementation: A perspective on the role of n-3 PUFA-derived lipid mediators